Global Blood Grouping Reagents Market Size Projected to

From GlobeNewswire: 2025-02-07 08:00:00

The Global Blood Grouping Reagents Market was valued at USD 1.97 billion in 2023, projected to reach USD 3.92 billion by 2032, with a CAGR of 7.97%. Growth is driven by increased chronic diseases, surgical procedures, and blood transfusion needs. Manufacturers are developing advanced blood typing systems for accuracy and efficiency, meeting stringent regulatory standards.

Key market trends include the adoption of automated blood typing systems, molecular techniques like PCR and MPS, regulatory compliance driving quality assurance, and increased surgical procedures and chronic diseases. Strategic partnerships and product innovations are shaping the market landscape.

Major players in the market include Merck KGaA, Bio-Rad Laboratories, Beckman Coulter, Haemokinesis Pty Ltd, and more. The market scope includes a size of USD 1.97 billion in 2023, growing at a CAGR of 7.97% from 2024 to 2032, with key growth drivers being accurate blood typing, automation in diagnostics, and rising chronic disease cases.

In the Blood Grouping Reagents Market, consumables accounted for 56.2% in 2023, driven by high demand in hospitals and blood banks. Instruments are expected to grow due to the adoption of automated analyzers. PCR-based and microarray techniques dominated in 2023, with MPS expected to be the fastest-growing segment for full genetic profiling of blood group antigens. The Blood Grouping Reagents Market offers various products for personalized transfusion medicine and transplantation compatibility. Recent developments include the discovery of the MAL blood group system and EU’s implementation of IVDR regulations. With over 118.5 million blood donations yearly, the market sees increased demand due to chronic diseases and advanced AI-driven testing systems.

Statistical insights reveal a growing demand for blood grouping reagents, driven by conditions like anemia and leukemia. The U.S. healthcare system has allocated over USD 1.5 billion for transfusion diagnostics, while FDA scrutiny is pushing for next-gen molecular blood typing techniques. The market is evolving rapidly to meet increasing demands and regulatory requirements.



Read more at GlobeNewswire: Global Blood Grouping Reagents Market Size Projected to